IMNM insider buying

3 cluster buys

Immunome Inc. · Healthcare

When two or more insiders at Immunome Inc. buy IMNM on the open market around the same time, that clustered conviction is one of the highest-signal patterns in SEC filing data. Below is every cluster we've detected in IMNM plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.

Clusters
3
Distinct insiders
5
Total bought
$7.5M
Market cap
$2.7B

Detected clusters

  • Dec 18, 2025 – Jun 5, 2026
    Detected Jun 5, 2026
    High conviction3 insiders
    Total bought
    $2.2M
    Market cap
    $2.7B
  • Nov 21, 2024 – Mar 26, 2025
    Detected Mar 26, 2025
    High conviction3 insiders
    Total bought
    $3.6M
    Market cap
    $2.7B
  • May 20 – Aug 16, 2024
    Detected Aug 16, 2024
    High conviction2 insiders
    Total bought
    $1.5M
    Market cap
    $2.7B

All notable open-market buys in IMNM

Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.

DateInsiderSharesPriceValueFiling
Jun 5, 2026
Director
6,000$19.48$116.9KSEC ↗
May 15, 2026
Director
5,000$20.70$103.5KSEC ↗
Mar 27, 2026
Director, President and CEO
25,450$19.67$500.6KSEC ↗
Mar 11, 2026
Director
1,000$21.55$21.6KSEC ↗
Mar 10, 2026
Director
1,000$22.12$22.1KSEC ↗
Dec 30, 2025
Director, President and CEO
4,729$21.15$100.0KSEC ↗
Dec 19, 2025
Chief Technical Officer
10,000$20.49$204.9KSEC ↗
Dec 19, 2025
Director, President and CEO
7,278$20.48$149.1KSEC ↗
Dec 18, 2025
Director, President and CEO
46,511$21.50$1.0MSEC ↗
Jun 3, 2025
Director
5,000$9.38$46.9KSEC ↗
Mar 26, 2025
Director, President and CEO
137,100$7.29$999.5KSEC ↗
Mar 25, 2025
Director
7,800$7.78$60.7KSEC ↗
Mar 24, 2025
Chief Technology Officer
12,300$8.42$103.6KSEC ↗
Mar 24, 2025
Director
7,000$8.21$57.5KSEC ↗
Jan 31, 2025
Director, President and CEO
150,000$7.75$1.2MSEC ↗
Nov 22, 2024
Director, President and CEO
33,943$9.78$332.0KSEC ↗
Nov 21, 2024
Director, President and CEO
66,057$9.54$630.2KSEC ↗
Nov 21, 2024
Chief Technology Officer
21,000$9.43$198.0KSEC ↗
Nov 21, 2024
Chief Medical Officer
15,805$9.48$149.8KSEC ↗
Aug 16, 2024
Director
7,000$13.94$97.6KSEC ↗
May 21, 2024
Director, President and CEO
20,434$13.78$281.6KSEC ↗
May 21, 2024
Director
2,000$13.57$27.1KSEC ↗
May 20, 2024
Director, President and CEO
79,566$13.91$1.1MSEC ↗

More Healthcare stocks with insider cluster buys

All insider buying in Healthcare

IMNM insider buying — FAQ

Are insiders buying IMNM stock?
Yes — 5 distinct insiders have bought IMNM (Immunome Inc.) on the open market, including 3 cluster buys where two or more insiders bought within a rolling window. The most recent qualifying activity was Jun 9, 2026.
How much IMNM stock have insiders bought?
Insiders have bought a combined $7.5M of IMNM across 23 open-market purchases, based on SEC Form 4 filings.
What is an insider cluster buy in IMNM?
A cluster buy is two or more distinct Immunome Inc. insiders — officers, directors, or 10% owners — each buying IMNM on the open market within a rolling window. IMNM has 3 detected cluster buys to date.
Where does this IMNM insider trading data come from?
Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

How we track insider buying in IMNM

We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy IMNM within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?

This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding IMNM.